A prospective multi-centre, randomized study comparing the addition of tapering dexamethasone to other standard of care therapies for taxane-associated pain syndrome (TAPS) in breast cancer patients-Reference-Cited by-同舟云学术

A prospective multi-centre, randomized study comparing the addition of tapering dexamethasone to other standard of care therapies for taxane-associated pain syndrome (TAPS) in breast cancer patients

Published:2021-03-19 Issue:10 Volume:29 Page:5787-5795
ISSN:0941-4355
Container-title:Supportive Care in Cancer
language:en
Short-container-title:Support Care Cancer

Author:

Clemons Mark^ORCID,Simos Demetrios,Sienkiewicz Marta,Ng Terry,Zibdawi Labib,Basulaiman Bassam,Awan Arif,Fergusson Dean,Vandermeer Lisa,Saunders Deanna,Hutton Brian,Amir Eitan,

Funder

Cancer Care Ontario

Publisher

Springer Science and Business Media LLC

Subject

Oncology

Link

https://link.springer.com/content/pdf/10.1007/s00520-021-06142-8.pdf

Reference29 articles.

1. Fernandes R, Mazzarello S, Hutton B, Shorr R, Majeed H, Ibrahim MF, Jacobs C, Ong M, Clemons M (2016) Taxane acute pain syndrome (TAPS) in patients receiving taxane-based chemotherapy for breast cancer-a systematic review. Support Care Cancer 24(8):3633–3650. https://doi.org/10.1007/s00520-016-3256-5

2. Sanofi-Aventis (2017) Taxotere (docetaxel for injection). http://products.sanofi.ca/en/taxotere.pdf. Accessed September 27 2018

3. Eckhardt S (1998) The effect of docetaxel on malignant tumors. Orv Hetil 139(15):867–872